Novel Serum Biomarkers for Patients with Allergic Asthma Phenotype

Novel Serum Biomarkers for Patients with Allergic Asthma Phenotype

In distinguishing the allergic asthma (AA) phenotype, it has been identified that specific biomarkers could assist; however, none of them are considered ideal. This study aimed to analyze three groups of biologically active substances in the serum. Twenty steroid-free AA patients, sensitized to <...

Full description

Bibliographic Details
Main Authors:	Jolita Palacionyte, Andrius Januskevicius, Egle Vasyle, Airidas Rimkunas, Ieva Bajoriuniene, Astra Vitkauskiene, Skaidrius Miliauskas, Kestutis Malakauskas
Format:	Article
Language:	English
Published:	MDPI AG 2024-01-01
Series:	Biomedicines
Subjects:	allergic asthma biomarker serum biologically active substance eosinophil fraction of exhaled nitric oxide total immunoglobulin E
Online Access:	https://www.mdpi.com/2227-9059/12/1/232

Similar Items

IL-5 and GM-CSF, but Not IL-3, Promote the Proliferative Properties of Inflammatory-like and Lung Resident-like Eosinophils in the Blood of Asthma Patients
by: Jolita Palacionyte, et al.
Published: (2022-11-01)

α<sub>4</sub>β<sub>1</sub> and α<sub>M</sub>β<sub>2</sub> Integrin Expression and Pro-Proliferative Properties of Eosinophil Subtypes in Asthma
by: Egle Jurkeviciute, et al.
Published: (2021-08-01)

Blood Inflammatory-like and Lung Resident-like Eosinophils Affect Migration of Airway Smooth Muscle Cells and Their ECM-Related Proliferation in Asthma
by: Airidas Rimkunas, et al.
Published: (2023-02-01)

Blood Eosinophils Subtypes and Their Survivability in Asthma Patients
by: Andrius Januskevicius, et al.
Published: (2020-05-01)

Asthmatic Eosinophils Alter the Gene Expression of Extracellular Matrix Proteins in Airway Smooth Muscle Cells and Pulmonary Fibroblasts
by: Ieva Janulaityte, et al.
Published: (2022-04-01)

Utilizing Predictive Inflammatory Markers for Guiding the Use of Biologicals in Severe Asthma
by: Runnstrom M, et al.
Published: (2022-01-01)

Clinical study of exhaled nitric oxide in children with asthma and allergic rhinitis
by: LI Pengyun, et al.
Published: (2023-06-01)

Asthmatic Eosinophils Promote Contractility and Migration of Airway Smooth Muscle Cells and Pulmonary Fibroblasts In Vitro
by: Ieva Janulaityte, et al.
Published: (2021-06-01)

Peripheral blood Th9 cells and eosinophil apoptosis in asthma patients
by: Deimantė Hoppenot, et al.
Published: (2015-01-01)

Diagnostic accuracy of blood eosinophils in comparison to other common biomarkers for identifying sputum eosinophilia in patients with chronic cough
by: Fang Yi, MD, PhD, et al.
Published: (2023-09-01)

Analysis of serum IgE and eosinophils in 80 patients with allergic dermatosis
by: Yi-xuan LI, et al.
Published: (2019-12-01)

Exhaled carbon monoxide in children with asthma and allergic rhinitis
by: Yulia Fatma Wardani, et al.
Published: (2022-04-01)

Characterization and Factors Associated with Poor Asthma Control in Adults with Severe Eosinophilic Asthma
by: Clara Padró-Casas, et al.
Published: (2023-07-01)

Study of Nasal Fractional Exhaled Nitric Oxide (FENO) in Children with Allergic Rhinitis
by: Sy Duong-Quy, et al.
Published: (2021-10-01)

Exhaled Nitric Oxide and Olfactory Dysfunction in Patients with Asthma: Association with Chronic Rhinosinusitis
by: Takashi Oda, et al.
Published: (2023-10-01)

CORRELATION ANALYSIS OF LABORATORY PARAMETERS IN SEASONAL ALLERGIC RHINITIS IN THE KARAGANDA REGION
by: S. R. Valieva, et al.
Published: (2022-06-01)

Winter Exercise and Speleotherapy for Allergy and Asthma: A Randomized Controlled Clinical Trial
by: Johanna Freidl, et al.
Published: (2020-10-01)

Changes in Left Heart Geometry, Function, and Blood Serum Biomarkers in Patients with Obstructive Sleep Apnea after Treatment with Continuous Positive Airway Pressure
by: Laima Kondratavičienė, et al.
Published: (2022-10-01)

Evaluation of Fractional Exhaled Nitric Oxide in Pediatric Asthma and Allergic Rhinitis
by: Yoon Young Jang, et al.
Published: (2020-12-01)

Which Child with Asthma is a Candidate for Biological Therapies?
by: Andrew Bush
Published: (2020-04-01)

Rapid onset of effect of benralizumab in a severe eosinophilic and allergic asthma patient with allergic bronchopulmonary aspergillosis
by: Arvindran Alaga, et al.
Published: (2023-06-01)

BAKER’S ASTHMA WITH OCULORHINITIS: CASE REPORT
by: Roberto Foti, et al.
Published: (2022-11-01)

ACO (Asthma–COPD Overlap) Is Independent from COPD, a Case in Favor: A Systematic Review
by: Naoya Fujino, et al.
Published: (2021-05-01)

Diagnosis and Treatment in Asthma and Allergic Rhinitis: Past, Present, and Future
by: Marta Espada-Sánchez, et al.
Published: (2023-01-01)

Small Airway Dysfunction Measured by Impulse Oscillometry and Fractional Exhaled Nitric Oxide Is Associated With Asthma Control in Children
by: Liang-Mei Lin, et al.
Published: (2022-06-01)

Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma
by: Celeste M. Porsbjerg, et al.
Published: (2024-04-01)

Type 2 Low Biomarker Stability and Exacerbations in Severe Uncontrolled Asthma
by: Arja Viinanen, et al.
Published: (2023-07-01)

Basophils Orchestrating Eosinophils’ Chemotaxis and Function in Allergic Inflammation
by: Joseena Iype, et al.
Published: (2021-04-01)

Clinical value of nitric oxide parameters in children with bronchial asthma
by: Wei Ziqian, Yilimuguli Abudukeremu, Wu Baojing
Published: (2023-08-01)

Vitamin D: A Silent Cofactor for Allergic Rhinitis
by: Rabi Hembrom, et al.
Published: (2019-08-01)

Vitamin D: A Silent Cofactor for Allergic Rhinitis
by: Rabi Hembrom, et al.
Published: (2019-08-01)

The Combined Value of Type2 Inflammatory Markers in Chronic Obstructive Pulmonary Disease
by: Yunhuan Liu, et al.
Published: (2022-05-01)

Impact of Therapeutics on Unified Immunity During Allergic Asthma and Respiratory Infections
by: Armando S. Flores-Torres, et al.
Published: (2022-03-01)

Omalizumab for the treatment of patients with severe allergic asthma with immunoglobulin E levels above >1500 IU/mL
by: Francesco Menzella, MD, et al.
Published: (2023-06-01)

Insufficiency of Laboratory Data in Reflecting Allergic Rhinitis Severity Based on the Allergic Rhinitis and Its Impact on Asthma Guideline in Korean Patients
by: Hae Eun Noh, et al.
Published: (2024-03-01)

Can nasal nitric oxide be a biomarker to differentiate allergic and non-allergic rhinitis?
by: A. F. Kalpaklioglu, et al.
Published: (2021-09-01)

OMALIZUMAB RIKE IN THERAPY OF GRAVE THERAPEUTICALLY RESISTENT ALLERGIC ASTHMA WITH INVOLVEMENT OF SMALL RESPIRATORY WAYS AND FIXED BRONCHIAL OBSTRUCTION. A LITERATURE REVIEW AND CLINICAL OBSERVATION
by: I. I. Vorzheva, et al.
Published: (2017-11-01)

Response to Omalizumab as an Add-On Therapy in the Treatment of Allergic Asthma in Adult Chinese Patients—A Retrospective Study
by: Na Li, et al.
Published: (2022-12-01)

Evaluation of Diagnostic Criteria for AFRS: A Hospital Based Study
by: Krishna V Chaitanya, et al.
Published: (2017-12-01)

Evaluation of Diagnostic Criteria for AFRS: A Hospital Based Study
by: Krishna V Chaitanya, et al.
Published: (2017-12-01)